# Jessie Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jessie-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,785 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 22 |
| i10-index | 33 |
| Last Known Institution | Angiocrine Bioscience (United States) |
| OpenAlex ID | https://openalex.org/A5065566858 |
| ORCID iD | 0000-0002-4539-3771 |
| Works | 108 |

## Researcher papers

- [Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis](https://scholariq.org/papers/pharmacokinetics-pharmacodynamics-and-safety-of-apixaban-in-subjects-with-end/)
- [Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects](https://scholariq.org/papers/safety-pharmacokinetics-and-pharmacodynamics-of-multiple-oral-doses-of-apixaban/)
- [Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects](https://scholariq.org/papers/effect-of-extremes-of-body-weight-on-the-pharmacokinetics-pharmacodynamics/)
- [Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban](https://scholariq.org/papers/effect-of-renal-impairment-on-the-pharmacokinetics-pharmacodynamics-and-safety/)
- [Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study](https://scholariq.org/papers/clinical-and-biological-predictors-of-response-to-standardised-paediatric/)
- [Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor<scp>X</scp>a inhibitor](https://scholariq.org/papers/effect-of-ketoconazole-and-diltiazem-on-the-pharmacokinetics-of-apixaban-an-oral/)
- [Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects](https://scholariq.org/papers/effect-of-activated-charcoal-on-apixaban-pharmacokinetics-in-healthy-subjects/)
- [Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor](https://scholariq.org/papers/chromogenic-laboratory-assays-to-measure-the-factor-xa-inhibiting-properties-of/)
- [A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban](https://scholariq.org/papers/a-randomized-direct-comparison-of-the-pharmacokinetics-and-pharmacodynamics-of/)
- [Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa](https://scholariq.org/papers/effect-of-rifampin-on-the-pharmacokinetics-of-apixaban-an-oral-direct-inhibitor/)
- [Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis](https://scholariq.org/papers/treatment-outcomes-associated-with-dupilumab-use-in-patients-with-atopic/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Retinal and Macular Surgery](https://scholariq.org/topics/retinal-and-macular-surgery/)
- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Researcher university

- [Angiocrine Bioscience (United States)](https://scholariq.org/institutions/angiocrine-bioscience-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.